CoChat

Structure-dependent inhibition of the ETS-family transcription factor PU.1 by novel heterocyclic diamidines

Open access

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Abstract

ETS transcription factors mediate a wide array of cellular functions and are attractive targets for pharmacological control of gene regulation. We report the inhibition of the ETS-family member PU.1 with a panel of novel heterocyclic diamidines. These diamidines are derivatives of furamidine (DB75) in which the central furan has been replaced with selenophene and/or one or both of the bridging phenyl has been replaced with benzimidazole. Like all ETS proteins, PU.1 binds sequence specifically to 10-bp sites by inserting a recognition helix into the major groove of a 5'-GGAA-3' consensus, accompanied by contacts with the flanking minor groove. We showed that diamidines target the minor groove of AT-rich sequences on one or both sides of the consensus and disrupt PU.1 binding. Although all of the diamidines bind to one or both of the expected sequences within the binding site, considerable heterogeneity exists in terms of stoichiometry, site-site interactions and induced DNA conformation. We also showed that these compounds accumulate in live cell nuclei and inhibit PU.1-dependent gene transactivation. This study demonstrates that heterocyclic diamidines are capable of inhibiting PU.1 by targeting the flanking sequences and supports future efforts to develop agents for inhibiting specific members of the ETS family.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/nar/gkt955

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Heterocyclic diamidines and DNA target site used in this study. (A) Compounds are colored to aid visualization of the succeeding figures. (B) The high-affinity λB site hairpin used in SPR experiments. The ETS consensus sequence (5′-GGAA-3′) is in bold.
Figure 1. Heterocyclic diamidines and DNA target site used in this study. (A) Compounds are colored to aid visualization of the succeeding figures. (B) The high-affinity λB site hairpin used in SPR experiments. The ETS consensus sequence (5′-GGAA-3′) is in bold.CC BY-NC · PubMed Central
Figure 2. SPR analysis of the dications binding to the λB site and inhibition of PU.1. (A) The binding of compounds to an immobilized DNA hairpin duplex harboring the λB site was determined by SPR. The r values (as explained in the Supplementary Methods) are plotted against compound concentration. An appropriate one or two site (DB293) model was used to fit the data. Additional points at higher concentration were used to obtain the KD values for DB75 and DB1213. DB1977 is similar to DB1976 and is not shown. Numerical estimates of KD are given in Table 1. (B) The protein inhibition signal in percentage is plotted against compound concentration. Numerical estimates of IC50 are given in Table 1. (C) Comparison of DNA-binding affinity and PU.1-inhibitory potency of DB compounds. For DB293, the KD value for binding the first equivalent of drug is used.
Figure 2. SPR analysis of the dications binding to the λB site and inhibition of PU.1. (A) The binding of compounds to an immobilized DNA hairpin duplex harboring the λB site was determined by SPR. The r values (as explained in the Supplementary Methods) are plotted against compound concentration. An appropriate one or two site (DB293) model was used to fit the data. Additional points at higher concentration were used to obtain the KD values for DB75 and DB1213. DB1977 is similar to DB1976 and is not shown. Numerical estimates of KD are given in Table 1. (B) The protein inhibition signal in percentage is plotted against compound concentration. Numerical estimates of IC50 are given in Table 1. (C) Comparison of DNA-binding affinity and PU.1-inhibitory potency of DB compounds. For DB293, the KD value for binding the first equivalent of drug is used.CC BY-NC · PubMed Central
Figure 3. DB293 induces distinct DNA conformations at the λB motif that are not shared by its homolog DB1281. A DNA fragment harboring the λB site was saturated with DB293 (0.1 mM) or DB1281 (1 µM) and probed by hydroxyl radicals (•OH). Shown here are the lane traces for the 5′-GGAA-3′ and 5′-TTCC-3′ strands; the experimental gel images are found in Supplementary Figure SD5. The pixel count is marked in the abscissa. Note the 3′→5′ direction from left to right. Although the two •OH footprints within the λB motif for DB1281 are apparent, neither strand exhibits protection by DB293 at S2. Instead, DB293 induces local hypersensitivity to •OH at both strands just 3′ to the CC. DNase I footprinting confirms the weak footprint at S1 and negligible occupancy at S2 for DB293 (Supplementary Figure SD1).
Figure 3. DB293 induces distinct DNA conformations at the λB motif that are not shared by its homolog DB1281. A DNA fragment harboring the λB site was saturated with DB293 (0.1 mM) or DB1281 (1 µM) and probed by hydroxyl radicals (•OH). Shown here are the lane traces for the 5′-GGAA-3′ and 5′-TTCC-3′ strands; the experimental gel images are found in Supplementary Figure SD5. The pixel count is marked in the abscissa. Note the 3′→5′ direction from left to right. Although the two •OH footprints within the λB motif for DB1281 are apparent, neither strand exhibits protection by DB293 at S2. Instead, DB293 induces local hypersensitivity to •OH at both strands just 3′ to the CC. DNase I footprinting confirms the weak footprint at S1 and negligible occupancy at S2 for DB293 (Supplementary Figure SD1).CC BY-NC · PubMed Central
Figure 4. The homologs DB1976 and DB1977 differentially recognize AT-rich sequences within the λB motif, a PU.1-specific binding site. A DNA fragment harboring the λB site was saturated with DB1976 (1 µM) or DB1977 (0.1 µM) and probed by DNase I (A and B) or hydroxyl radicals (•OH; C and D). Shown here are the lane traces for the 5′-GGAA-3′ and 5′-TTCC-3′ strands; the experimental gel images are found in Supplementary Figure SD6. The pixel count is marked in the abscissa. Note the 3′ → 5′ direction from left to right. Bases marked by hollow symbols (square, circle) are significantly more protected against DNase I by DB1976 than DB1977. DNase I protection by DB1976 may, therefore, be considered as a single, extended footprint. Whereas the two •OH footprints for DB1976 are apparent (S1 ad S2), neither strand exhibits protection by DB1977 at S2.
Figure 4. The homologs DB1976 and DB1977 differentially recognize AT-rich sequences within the λB motif, a PU.1-specific binding site. A DNA fragment harboring the λB site was saturated with DB1976 (1 µM) or DB1977 (0.1 µM) and probed by DNase I (A and B) or hydroxyl radicals (•OH; C and D). Shown here are the lane traces for the 5′-GGAA-3′ and 5′-TTCC-3′ strands; the experimental gel images are found in Supplementary Figure SD6. The pixel count is marked in the abscissa. Note the 3′ → 5′ direction from left to right. Bases marked by hollow symbols (square, circle) are significantly more protected against DNase I by DB1976 than DB1977. DNase I protection by DB1976 may, therefore, be considered as a single, extended footprint. Whereas the two •OH footprints for DB1976 are apparent (S1 ad S2), neither strand exhibits protection by DB1977 at S2.CC BY-NC · PubMed Central
Figure 5. Inhibition of PU.1-specific gene transactivation in live cells. (A) PU.1 activity was assayed using an EGFP reporter under the control of a minimal TATA-box promoter. An enhancer element consisting of five tandem λB sites, spaced one helical turn apart, confers specificity to PU.1. Reporter expression was measured by flow cytometry. The HEK293 cells, which do not express PU.1, do not activate the reporter except in the presence of exogenous PU.1 (as shown in fluorescence micrograph). (B) PU.1-expressing HEK293 cells were transfected with reporter plasmid with or without DB1976, DB1977 or DB1281 in the culture medium at the indicated concentrations. EGFP fluorescence was measured by flow cytometry after 24 h. The effect of the compounds on cell viability was separately determined by resazurin reduction.
Figure 5. Inhibition of PU.1-specific gene transactivation in live cells. (A) PU.1 activity was assayed using an EGFP reporter under the control of a minimal TATA-box promoter. An enhancer element consisting of five tandem λB sites, spaced one helical turn apart, confers specificity to PU.1. Reporter expression was measured by flow cytometry. The HEK293 cells, which do not express PU.1, do not activate the reporter except in the presence of exogenous PU.1 (as shown in fluorescence micrograph). (B) PU.1-expressing HEK293 cells were transfected with reporter plasmid with or without DB1976, DB1977 or DB1281 in the culture medium at the indicated concentrations. EGFP fluorescence was measured by flow cytometry after 24 h. The effect of the compounds on cell viability was separately determined by resazurin reduction.CC BY-NC · PubMed Central
Figure 6. Localization of DB compounds in live unfixed HEK293 cells. (A) The uptake of DB1281, DB1976, and DB1977 by HEK293 cells and colocalization with DOX were monitored by fluorescence microscopy as described in ‘Materials and Methods’. Arrows indicate cells that show particularly strong DOX staining in DB1281. (B) Quantitative colocalization analysis of the dications and DOX fluorescence in terms of spatial co-distribution and intensity correlation. DB1281 correlates comparably as DB1976 and DB1977 in terms of spatial codistribution with DOX but not DOX intensity.
Figure 6. Localization of DB compounds in live unfixed HEK293 cells. (A) The uptake of DB1281, DB1976, and DB1977 by HEK293 cells and colocalization with DOX were monitored by fluorescence microscopy as described in ‘Materials and Methods’. Arrows indicate cells that show particularly strong DOX staining in DB1281. (B) Quantitative colocalization analysis of the dications and DOX fluorescence in terms of spatial co-distribution and intensity correlation. DB1281 correlates comparably as DB1976 and DB1977 in terms of spatial codistribution with DOX but not DOX intensity.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 50 references

Research works printed but not linked: 3

  1. 2012, 8, 297
  2. Lansiaux, 2002, Cancer Research, 62, 7219
  3. Paine, 2010, Current opinion in investigational drugs (London, England : 2000), 11, 876

Cited by

See all 68

Metadata

Authors
Munde, M., Wang, S., Kumar, A., Stephens, C. E., Farahat, A. A., Boykin, D. W., Wilson, W. D., & Poon, G. M. K.
Affiliations
Georgia State University (US)
Corresponding author
Poon, G. M. K.
Venue
Nucleic Acids Research
Published
2013-10-23
Volume
42
Issue
2
Pages
1379-1390
ISSN
  • 0305-1048 (ISSN-L)
  • 1362-4962
OpenAlex
W2155557355
Cited by
68
References
50
Citations by year
2025: 1 · 2024: 6 · 2023: 8 · 2022: 9 · 2021: 4 · 2020: 5 · 2019: 7 · 2018: 11 · 2017: 6 · 2016: 5 · 2015: 1 · 2014: 5
FWCI
1.64
Type
journal article
Language
en
Open access
Locations
  • Nucleic Acids Research (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Digital Archive @ GSU (submittedVersion, cc-by-nc)
  • Counseling And Psychological Services Dissertations (Georgia State University) (submittedVersion, cc-by-nc)
Funders
  • Washington State University
  • National Institute of Allergy and Infectious Diseases (R01AI064200, AI064200)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
  • Health Sciences › Medicine › Oncology › Metal complexes synthesis and properties
  • Physical Sciences › Chemistry › Organic Chemistry › Synthesis and pharmacology of benzodiazepine derivatives
Keywords
PU.1, ETS transcription factors, selenophene, benzimidazole, minor groove binding, DNA binding inhibition, AT-rich sequences, transcriptional repression, gene transactivation, structure-activity relationship
MeSH terms
Proto-Oncogene Protein Spi-1, Benzamidines, Binding Sites, DNA, Humans, Immunoglobulin lambda-Chains, Nucleic Acid Conformation, Proto-Oncogene Proteins, Transcriptional Activation, Trans-Activators, AT Rich Sequence, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Structure-dependent inhibition of the ETS-family transcription factor PU.1 by novel heterocyclic diamidines. https://app.cochat.ai/papers/10.1093/nar/gkt955
The paper
Munde, M., Wang, S., Kumar, A., Stephens, C. E., Farahat, A. A., Boykin, D. W., Wilson, W. D., & Poon, G. M. K. (2014). Structure-dependent inhibition of the ETS-family transcription factor PU.1 by novel heterocyclic diamidines. Nucleic Acids Research. https://doi.org/10.1093/nar/gkt955

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.